Large Molecule Bioanalysis done differently

To help you achieve more.

BioAgilytix has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.

Services Delivered Scientist to Scientist

Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.

biomarkers

Biomarkers

immunogenicity

Immunogenicity

pharmacokinetics

Pharmacokinetics (PK)

cell-based-assays

Cell-Based Assays

Solutions Enabled by World-Leading Expertise

Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.

biosimilars

Biosimilars

gene-therapy

Gene Therapy

antibody-drug-conjugates

Antibody Drug Conjugates (ADCs)

immuno-oncology

Immuno-oncology

The Bioagilytix Perspective

Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.

resource center

Visit Resource Center

usa europe labs

Advanced facilities to support all phases of large molecule global studies.

    LinkedIn Company Updates

  • 1 Day Agoview on linkedin

    BioAgilytix

    We are excited to announce that BioAgilytix has been recognized as one of Triangle Business Journal’s 2018 Leaders in Diversity winners! This marks the third time that we’ve been honored with this award, and are proud of the fact that BioAgilytix employees now represent over 25 countries from all over the world: https://lnkd.in/gVDaY6G

  • 1 Day Agoview on linkedin

    BioAgilytix

    Join BioAgilytix’s Todd Lester on August 17th during the Annual Congress of International Drug Discovery Science and Technology for a presentation entitled “Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment”. Register here: https://lnkd.in/gzVXksj

  • 4 Days Agoview on linkedin

    BioAgilytix

    Using new techniques that enable researchers to study gene expression, scientists have identified a rare cell type in airways that appears to play a key role in the biology of cystic fibrosis. This work could have broad implications for all diseases of the airway, including asthma, chronic obstructive pulmonary disease, and bronchitis. https://lnkd.in/gBw3jSf via Genetic Engineering & Biotechnology News